Address
Registered office address 4 Dorset Road, London, England, SE9 4QT
Work Hours
Monday to Friday: 7AM - 10PM
Weekend: 9AM - 8PM
Email Us
enquiries@vantixbio.co.uk.
Address
Registered office address 4 Dorset Road, London, England, SE9 4QT
Work Hours
Monday to Friday: 7AM - 10PM
Weekend: 9AM - 8PM
Email Us
enquiries@vantixbio.co.uk.

£58.00 – £69.00Price range: £58.00 through £69.00
A 16-amino-acid synthetic fragment analogue of the C-terminus of human growth hormone. Studied in metabolic literature for lipolytic activity.
Find quick answers to the questions researchers ask us most often.
Yes. Every batch is verified through HPLC testing by Janoshik Analytical.
Every product supplied by us is independently analysed by Janoshik Analytical, an independent peptide testing laboratory based in the Czech Republic. HPLC testing consistently reports purity levels exceeding 99%.
Where a Certificate of Analysis (COA) is available for the current production batch, a printed copy is included with your order. If a printed certificate has not yet been issued, the latest batch verification can be viewed on our Purity page.
Each COA contains a unique verification code that can be validated directly through Janoshik’s online verification portal, allowing researchers to independently confirm the authenticity of the report. We also provide a guide explaining how to interpret Janoshik HPLC certificates.
Follow these four simple steps:
The quick-reference reconstitution guide printed inside the box lid can be used whenever you prepare another vial.
Clean the pen tip with an alcohol wipe before attaching a fresh sterile needle supplied with the kit.
Turn the dose selector one click, point the pen upwards and press the injection button. A small droplet at the needle tip confirms the pen has been primed and any trapped air has been removed.
Each click delivers a fixed increment depending on the pen calibration, typically 0.5-1 mg per click. The dose window displays the total selected dose.
For example, a 6 mg research dose generally corresponds to approximately 6-12 clicks.
Published research protocols commonly describe subcutaneous administration into the abdomen, thigh or upper arm. Hold the pen in place for approximately six seconds before withdrawing.
Dispose of the used needle in an approved sharps container, replace the cap and return the pen to refrigerated storage.
Each pen provides the number of doses indicated in the protocol guide for your selected size. When empty, simply replace the cartridge while continuing to use the same pen body. Current refill pricing is available in the calculator above.
Research use only. This information summarises procedures reported in published scientific literature and is not intended as medical or human-use guidance.
Published pharmacokinetic and clinical research involving AOD9604 commonly describes subcutaneous administration into the abdomen, thigh or upper arm. Study protocols typically recommend rotating administration sites to minimise local tissue irritation.
Research use only. This information is provided for scientific context based on published peer-reviewed literature. We do not provide medical advice, dosing recommendations or administration instructions.
Reference: Heffernan et al. (2001).
The simplest approach is to follow the protocol guide shown above. Published AOD9604 studies generally employ a gradual protocol progression, beginning with the lowest phase before increasing at predetermined intervals. The highlighted maintenance phase represents where many research cohorts remain during ongoing investigation.
If you are beginning work with this compound, complete Phase 1 before progressing to the next stage. Following the published study design mirrors the methodology described in the available literature.
Researchers already familiar with AOD9604 can select the relevant protocol phase to view expected product duration and estimated cost based on the chosen vial or pen size.
If your laboratory follows a customised research schedule, contact us before ordering and we’ll help identify the most appropriate product size for your protocol.
Research use only. The protocol information above is summarised from published scientific literature and is provided solely for laboratory reference. It should not be interpreted as medical advice or guidance relating to human use.
Reference: Heffernan et al. (2001).
| Specification | Details |
|---|---|
| Compound | AOD9604 |
| Research Category | Metabolic Research |
| Available Sizes | 2 mg, 5 mg, 10 mg |
| Pricing | From £58 |
| Format | Lyophilised powder supplied in a sealed glass vial |
| Purity | >99% by HPLC (Janoshik Analytical, independently batch verified) |
| Intended Use | In-vitro laboratory research only. Not for human consumption. |
The specifications below are compiled from publicly available scientific databases and peer-reviewed publications for laboratory reference.
| Property | Value |
|---|---|
| Compound Class | Synthetic 16-amino-acid fragment of human growth hormone (hGH 176–191) |
| Molecular Formula | C78H123N23O23S2 |
| Molecular Weight | 1817.1 g/mol |
| CAS Registry Number | 221231-10-3 |
| PubChem CID | 16131208 |
| Amino Acid Residues | 16 |
| Amino Acid Sequence | H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH |
| Mechanism | Reported in the literature as a modulator of lipolysis pathways with no direct GH receptor binding |
| Reported Half-Life | Short serum half-life reported in preclinical studies |
| Solubility | Reconstitutes in bacteriostatic water for laboratory applications |
| Lyophilised Storage | Stable at 2–8°C for 24 months or longer |
| Reconstituted Storage | Store at 2–8°C and use within 14 days |
| Regulatory Status | Investigational research compound |
AOD9604 is a synthetic peptide comprising amino acid residues 176–191 from the C-terminal region of human growth hormone. The peptide contains a disulfide bridge and has been characterised in preclinical literature for investigation into lipolysis-related pathways in adipocyte models. It is supplied as a lyophilised powder intended exclusively for in-vitro laboratory research.
The description above reflects published scientific literature and should not be interpreted as a claim regarding effects in humans.
AOD9604 is supplied as a freeze-dried powder in a sealed glass vial.
For laboratory preparation:
Our Reconstitution Volume Calculator can be used to determine the resulting concentration (mg/mL).
| State | Storage Temperature | Typical Shelf Life |
|---|---|---|
| Lyophilised | 2–8°C or -20°C | Up to 24 months |
| Reconstituted | 2–8°C | Up to 14 days |
Every batch of AOD9604 supplied by Vantix Bio undergoes independent HPLC analysis by Janoshik Analytical. Where available, a Certificate of Analysis accompanies each order and includes a unique verification code that can be authenticated directly through Janoshik’s verification platform. Reported purity consistently exceeds 99%.
Researchers investigating AOD9604 frequently also study:
Comparison resources are also available for AOD9604 vs 5-Amino-1MQ, covering mechanism of action, laboratory handling and pricing.
| Size | 5mg |
|---|---|
| Format | Pen, Vial |





Reviews
There are no reviews yet.